ARK Proposes Longevity ETF Targeting Technologies to Extend Lifespan

ARK Investment Management has filed for the ARK Longevity ETF, an actively managed strategy focused on companies developing technologies intended to extend human lifespan and improve long-term health. The fund will target businesses advancing cellular reprogramming, epigenetics, gene and cell therapies, metabolic health, preventive diagnostics and whole-body screening. The strategy aims to capture investment opportunities emerging from efforts to slow biological aging and address age-related disease through scientific innovation. The proposed ETF expects significant exposure through total return swaps, complemented by direct equity and potentially private investments.